CollPlant Biotechnologies Ltd (CLGN) stock
CLGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as OPHI
$3.96+0.06 (+1.54%)
Close on Nov 11, 2026Market cap $5.72MP/E –Yield –
CollPlant Biotechnologies price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
CollPlant Biotechnologies's price to sales ratio was 2.4× on Nov 11, 2026, against 54.0× a year earlier. Over the last 5 years it ranged from 1.5× to 305.3×, with a median of 7.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.4× | −32.2 |
| 2025 | Dec 31, 2025 | 34.6× | +30.8 |
| 2024 | Dec 31, 2024 | 3.8× | −240.0 |
| 2023 | Dec 29, 2023 | 243.8× | +238.0 |
| 2022 | Dec 30, 2022 | 5.8× | −21.6 |
| 2021 | Dec 31, 2021 | 27.3× | −2.7 |
| 2020 | Dec 31, 2020 | 30.1× | +25.1 |
| 2019 | Dec 31, 2019 | 5.0× | −19.2 |
| 2018 | Dec 31, 2018 | 24.2× | – |
See a number that looks wrong?